What is the Difference Between Myasthenia Gravis and Lambert Eaton Syndrome?
🆚 Go to Comparative Table 🆚Myasthenia Gravis (MG) and Lambert-Eaton Myasthenic Syndrome (LEMS) are both autoimmune diseases that impact muscle functions and cause muscle weakness. However, they differ in several aspects, including cause, risk factors, onset and progression, diagnosis, treatment, and the population they predominantly affect. Some key differences between MG and LEMS are:
- Cause: In MG, the interruption in muscle-nerve communication is caused by antibodies blocking the receptor for the neurotransmitter acetylcholine. In LEMS, the interruption is caused by an insufficient release of acetylcholine.
- Symptom Onset: MG typically presents with initial weakness involving extraocular muscles (muscles around the eyes). In contrast, LEMS symptoms often start in the limbs, with the legs feeling heavy and fatiguing easily.
- Muscle Weakness Distribution: Muscle weakness in MG tends to develop in a craniocaudal direction (from the head down to the feet), while in LEMS, it develops in the opposite direction.
- Risk Factors: MG is more commonly affected in women than men, with a ratio of about 2:1. LEMS, on the other hand, is more commonly associated with lung cancer and other autoimmune diseases.
- Diagnosis: Both MG and LEMS share similarities in symptoms, but they can be differentiated through various diagnostic tests, such as repetitive nerve stimulation and single-fiber electromyography.
- Treatment: Treatment for MG often involves medications like neostigmine, pyridostigmine, and corticosteroids, while LEMS may require different medications and treatments, such as cholinesterase inhibitors and immunosuppressive drugs.
Understanding the key differences between these two medical conditions can help patients and healthcare professionals make informed decisions regarding diagnosis and treatment.
Comparative Table: Myasthenia Gravis vs Lambert Eaton Syndrome
Myasthenia Gravis (MG) and Lambert-Eaton Myasthenic Syndrome (LEMS) are two autoimmune diseases that impact muscle functions and cause muscle weakness. Here is a table comparing the key differences between the two conditions:
Feature | Myasthenia Gravis (MG) | Lambert-Eaton Myasthenic Syndrome (LEMS) |
---|---|---|
Typical First Symptom | Diplopia (double vision) | Difficulty arising from bed or chair |
Autonomic Symptom | None | Dry mouth |
Weakest Muscles | Extraocular | Proximal leg |
Deep Tendon Reflexes | Normal | Decreased |
High Frequency Repetitive Nerve Stimulation | <60% increase in muscle action potential | >60% increase in muscle action potential |
Autoantibody Target | Postsynaptic acetylcholine receptor | Presynaptic voltage-gated calcium channel |
Age of Onset | More prevalent in young women in their 20s or 30s and older men in their 60s or 70s | More common in middle-aged adults, especially those with small lung cancer and a history of smoking |
Both MG and LEMS share similarities in symptoms, but they differ in cause, risk factors, onset and progression, diagnosis, and treatment, as well as the population they predominantly affect. Understanding the key differences between these two medical conditions can help patients and healthcare providers make informed decisions about diagnosis and treatment.
- Myasthenia Gravis vs Lambert Eaton Myasthenic Syndrome
- Guillain Barre Syndrome vs Myasthenia Gravis
- Muscular Dystrophy vs Myasthenia Gravis
- Myasthenia Gravis vs Cholinergic Crisis
- Parkinson’s vs Myasthenia Gravis
- Transverse Myelitis vs Guillain Barre Syndrome
- Myasthenic Crisis vs Cholinergic Crisis
- Muscular Dystrophy vs Myotonic Dystrophy
- Dravet Syndrome vs Lennox-Gastaut Syndrome
- Multiple Sclerosis vs Motor Neuron Disease
- Myopathy vs Neuropathy
- Myositis vs Rhabdomyolysis
- Motor Neuron Disease vs Muscular Dystrophy
- ALS vs MND
- Lupus vs Sjogren’s Syndrome
- Dermatomyositis vs Polymyositis
- Spinal Muscular Atrophy vs Muscular Dystrophy
- Polio vs Guillain Barre Syndrome
- Polymyositis vs Polymyalgia Rheumatica